Li X, Zheng M, Ma S, Nie F, et al. YTHDC1 is a therapeutic target for B-cell acute lymphoblastic leukemia by attenuating DNA damage response through the KMT2C-H3K4me1/me3 epigenetic axis. Leukemia 2024 Nov 5. doi: 10.1038/s41375-024-02451.
PMID: 39501105